Loading insider details...
Beta
Latest Form 4 (Jul 7, 2026): Exercise/Conversion of 9,014 INMB shares, $12.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Inmune Bio, Inc. (INMB) | Exercise/Conversion | 9,014 | $12.6K |
| Dec 2, 2025 | Inmune Bio, Inc. (INMB) | Grant/Award | 750,000 | n/a |
| Nov 18, 2025 | Inmune Bio, Inc. (INMB) | Disposition to Issuer | 400,000 | n/a |
| Dec 9, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 223,000 | n/a |
| Sep 30, 2024 | Inmune Bio, Inc. (INMB) | Purchase | 10,000 | $52.9K |
| Sep 17, 2024 | Inmune Bio, Inc. (INMB) | Purchase | 7,690 | $49.0K |
| May 16, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 160,000 | n/a |
| Apr 23, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 18,028 | $150.0K |
| Mar 20, 2023 | Inmune Bio, Inc. (INMB) | Purchase | 2,500 | $16.1K |
| Feb 21, 2023 | Inmune Bio, Inc. (INMB) | Grant/Award | 160,000 | n/a |